Diane Scott

Diane is an internationally recognized entrepreneur, venture capitalist and philanthropist with a track record for delivering results. She is co-founder of SX2 Ventures, an international venture capital business that focuses on innovation and value creation in the human care sector.

She is also currently Chairman and CEO of the Company’s largest investment, JMCC Group and was recently described by Forbes as the company’s “savvy CEO.”

Through her role at JMCC, Diane is helping revolutionize international patient access to medicinal cannabis by being the only company to be specifically invited, and the only company from the Caribbean region, to participate in Project Twenty21, the world’s largest observational medical cannabis study. She also developed JMCC Scientific, a division that encompasses medical product R&D, testing, manufacturing, packaging and labelling.

Diane Scott brings over 20 years of global experience in the C-suite of enterprises in global emerging industries.

Recently named as one of North America’s top female CEOs in the industry by MJ Business, Diane helms a rapidly growing business with contracted revenues from customers in Canada, Germany, Australia and Brazil.

Diane is a regular international speaker, participating in the prestigious International Economic Forum of the America's Toronto event. Diane was also recently appointed as Founding Partner of the Centre of Medicinal Cannabis in London, a group working to help shape the UK’s new medicinal cannabis regime.

Diane is also an advisor to several corporations and non-profit groups, including the Executive Advisory Board for Twenty21. Furthermore, she is an Activator at SheEO, a global community of radically generous women supporting women-led ventures. In that capacity, Diane invests in women-led enterprises around the world. She is a seasoned entrepreneur with a reputation for knocking down barriers in both business and social communities.